KOREA WHO
-
-
-
CEO of AprilBio
Cha Sang-hun
Professor-Turned-CEO Leads AprilBio’s Billion-Dollar Global Push
-
Last Updated on Nov 12, 2025
-
CEO of AprilBio
Life Summary
Cha Sang-hun is the CEO of AprilBio.
He aims to build a global biotech company centered on platform technology.
He was born in January 1963.
After majoring in environmental science at Kangwon National University, he earned his master’s and doctoral degrees in microbiology and immunology in the United States.
While serving as a professor at the College of Biomedical Science at Kangwon National University, he founded AprilBio in 2013 with his students as a university-based startup.
He holds SAFA, a platform technology that extends the half-life of therapeutic proteins.
He is recognized as a strategy-oriented leader focused on technology.
He is concentrating on advancing platform technology, expanding indications, and strengthening the global network.
#AprilBio #ChaSanghun #biotech #platformtechnology #SAFA #immunology #KangwonNationalUniversity #biopharma #innovation #globalexpansion
He aims to build a global biotech company centered on platform technology.
He was born in January 1963.
After majoring in environmental science at Kangwon National University, he earned his master’s and doctoral degrees in microbiology and immunology in the United States.
While serving as a professor at the College of Biomedical Science at Kangwon National University, he founded AprilBio in 2013 with his students as a university-based startup.
He holds SAFA, a platform technology that extends the half-life of therapeutic proteins.
He is recognized as a strategy-oriented leader focused on technology.
He is concentrating on advancing platform technology, expanding indications, and strengthening the global network.
#AprilBio #ChaSanghun #biotech #platformtechnology #SAFA #immunology #KangwonNationalUniversity #biopharma #innovation #globalexpansion